Aspirin-induced lipid mediator
- 专利权人:
- ザ・ブリガーム・アンド・ウーメンズ・ホスピタル・インコーポレーテッド
- 发明人:
- サーハン,チャールズ・エヌ,クリッシュ,クラリィ・ビー,サーハン,チャールズ・エヌ,クリッシュ,クラリィ・ビー
- 申请号:
- JP2014140321
- 公开号:
- JP5973503B2
- 申请日:
- 2014.07.08
- 申请国别(地区):
- JP
- 年份:
- 2016
- 代理人:
- 摘要:
- Aspirin triggered lipid mediators (ATLMs) are disclosed which are useful for the treatment or prevention of inflammation associated with various diseases, including ischemia.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- METHOD OF INHIBITING COAGULATION ACTIVATION WITH HUMAN ANTI-FACTOR V ANTIBODIES AND USE THEREOF
- Macrophage activating factor for use in the treatment of chronic fatigue syndrome (CFS) and CFS-related diseases and disorders
- MACROPHAGE ACTIVATING FACTOR FOR USE IN THE TREATMENT OF CHRONIC FATIGUE SYNDROME (CFS) AND CFS-RELATED DISEASES AND DISORDERS
- COMPOSITIONS COMPRISING GC- MACROPHAGE ACTIVATING FACTOR AND USES THEREOF
- Peptides targeting nuclear factor κB activating receptor (RANK) and their applications